Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-25T06:07:20.727Z Has data issue: false hasContentIssue false
  • English
  • Français

TRANSFERABILITY OF HEALTH TECHNOLOGY ASSESSMENT REPORTS IN LATIN AMERICA: AN EXPLORATORY SURVEY OF RESEARCHERS AND DECISION MAKERS

Published online by Cambridge University Press:  26 April 2012

Andres Pichon-Riviere ,
Federico Augustovski ,
Sebastián García Martí ,
Sean D. Sullivan  and
Michael Drummond
Andres Pichon-Riviere
Affiliation:
Institute for Clinical Effectiveness and Health Policy (IECS) and University of Buenos Aires email: apichon@iecs.org.ar
Federico Augustovski
Affiliation:
Institute for Clinical Effectiveness and Health Policy and University of Buenos Aires
Sebastián García Martí
Affiliation:
Institute for Clinical Effectiveness and Health Policy
Sean D. Sullivan
Affiliation:
University of Washington
Michael Drummond
Affiliation:
University of York
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction: HTA agencies, especially in developing countries, are under resourced and unable to conduct the desired amount of assessments. Adapting HTA reports (HTAs) from other jurisdictions is an alternative for saving resources.

Objectives: To explore HTA transferability experiences in Latin-America and Caribbean (LAC): are decision makers (DMs) using HTAs from other jurisdictions? Are researchers adapting HTAs when developing local reports? How useful is the information found in HTAs from other jurisdictions?

Methods: Web-based survey sent to 13031 HTA researchers and DMs.

Results: We received 671 responses from 19 countries. DMs reported using HTAs from other jurisdictions to guide decisions in the majority of the situations: 52.6 percent HTAs from outside LAC (e.g., Europe), 23.1 percent from other LAC countries, and only 24.3 percent HTAs from their own countries. 63 percent of researchers reported using HTAs from other jurisdictions. Usefulness scored significantly higher for HTAs from other jurisdictions as compared to local HTAs (7.1 versus 6.0 in a 1–10 scale; p < .01). Both DMs and researchers considered the information regarding safety and effectiveness more applicable than the information on social aspects, or economic evaluation. Barriers that limit transferability had significantly different scores for HTAs from other LAC countries as compared to those from regions outside LAC (i.e., poor methodological quality 6.7 versus 5.3, different epidemiological context 6.0 versus 7.4; all p < .01).

Conclusions: HTAs from outside the region are commonly used. However, DMs and researchers agreed that HTAs from LAC had the greatest potential for transferability, provided that barriers such as poor methodological quality could be overcome.

Keywords

Health technology assessmentHealth policyLatin AmericaTransferability
Type
POLICIES
Information
International Journal of Technology Assessment in Health Care , Volume 28 , Issue 2 , April 2012 , pp. 180 - 186
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Augustovski, F, Iglesias, C, Manca, A, et al. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27:919–929.Google Scholar
2.Augustovski, F, Bastardo, Y, Caso, A, et al. Pharmacoeconomics and outcomes research in Latin America: Argentina, Brazil, Chile, Colombia, and Mexico. ISPOR Connections; 2008.Google Scholar
3.Banta, D. Health technology assessment in Latin America and the Caribbean. Int J Technol Assess Health Care. 2009;25 (Suppl 1):253–254.CrossRefGoogle ScholarPubMed
4.Barbieri, M, Drummond, M, Rutten, F, et al. ISPOR Good Research Practices Economic Data Transferability Task Force. What do international pharmacoeconomic guidelines say about economic data transferability? Value Health. 2010;13:1028–1037.Google Scholar
5.Bertozzi, S, Valencia Mendoza, A, Hernández Garduño, C, et al. Guía Para la Conducción de Estudios de Evaluación Económica Para la Actualización del Cuadro Básico de Insumos del Sector Salud en México. Cuernavace, Mexico: Instituto Nacional de Salud Pública; 2008.Google Scholar
6.Boulenger, S, Nixon, J, Drummond, M, et al. Can economic evaluations be made more transferable? Eur J Health Econ. 2005;6:334–346.Google Scholar
7.Carrasquilla Gutierrez, G. Guía Metodológica para la Elaboración de Guías de Práctica Clínica Basadas en la Evidencia, de Evaluaciones Económicas y de Evaluación del Impacto de la Implementación de las Guías en el POS y en la Unidad de Pago por Capitación del Sistema General de Seguridad Social en Salud Colombiano. Colombia: Ministerio de la Protección Social Colciencias; 2008. www.pos.gov.co/Documents/GUIA%20METODOL%C3%93GICA%2023%2011%2009-1.pdf.Google Scholar
8.Chase, D, Rosten, C, Turner, S, Hicks, N, Milne, R. Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts. Health Technol Assess. 2009;13:1–142, iii.CrossRefGoogle ScholarPubMed
9.Drummond, M, Barbieri, M, Cook, J, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12:409–418.CrossRefGoogle ScholarPubMed
10.Essers, BA, Seferina, SC, Tjan-Heijnen, VC, et al. Transferability of model-based economic evaluations: The case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands. Value Health. 2010;13:375–380.CrossRefGoogle ScholarPubMed
11.Estudos de avaliaçao econômica de tecnologias em saúde. Normas e Manuais Técnicos. Brasil: Ministerio da Saúde; 2009. http://bvsms.saude.gov.br/bvs/publicacoes/avaliacao_economica_tecnologias_saude_2009.pdf.Google Scholar
12.Gálvez González, A. Guía Metodológica Para la Evaluación Económica en Salud: Cuba 2003. Cuba: Ministerio de Salud Pública, Escuela Nacional de Salud Pública; 2003. www.ispor.org/peguidelines/source/MethodologicalGuidelinesforHealthEconomicEvaluationsinCuba.pdf.Google Scholar
13.Goeree, R, Burke, N, O'Reilly, D, et al. Transferability of economic evaluations: Approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin. 2007;23:671–682.CrossRefGoogle Scholar
14.Guía Para la Elaboración de Informes de Evaluación de Tecnologías Sanitarias. Mercosur (2008) www.saludinvestiga.org.ar/pdf/resoluciones/Res-52-08_ES_GuiaElaboInfTecnoSanit.pdf.Google Scholar
15.Iglesias, CP, Drummond, MF, Rovira, J. Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care. 2005;21:1–14.CrossRefGoogle ScholarPubMed
16.INAHTA: International Network of Agencies for Health Technology Assessment (INAHTA). http://www.inahta.org (accessed March 5, 2011).Google Scholar
17.Neto, G. Utilizaçao de diretrizes nacionais e internacionais para execuçao da avaliaçao de tecnologias em saúde. In: Nita, M, ed. Avaliaçao de Tecnologias em Saúde. Artmed, Porto Alegre, Brazil; 2010:506–529.Google Scholar
18.Nixon, J, Rice, S, Drummond, M, et al. Guidelines for completing the EURONHEED transferability information checklists. Eur J Health Econ. 2009;10:157–165.Google Scholar
19.Pichon-Riviere, A, Augustovski, F, Rubinstein, A, et al. Health technology assessment for resource allocation decisions: Are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010;26:421–427.Google Scholar
20.Sculpher, MJ, Pang, FS, Manca, A, et al. Generalisability in economic evaluations studies in health care: A review and case studies. Health Technol Assess. 2004;8:iii-iv, 1–192.Google Scholar
21.Singer, ME. Cost-effectiveness analysis: Developing nations left behind. Pharmacoeconomics. 2008;26:359–561.CrossRefGoogle ScholarPubMed
22.Turner, S, Chase, DL, Milne, R, et al. European network for Health Technology Assessment (EUnetHTA). The health technology assessment adaptation toolkit: Description and use. Int J Technol Assess Health Care. 2009;25 (Suppl 2):37–41.Google Scholar
23.Turner, S, Chase, DL, Milne, R, et al. The adaptation of health technology assessment reports: Identification of the need for, and development of, a toolkit to aid the process. Int J Technol Assess Health Care. 2009;25 (Suppl 2):28–36.CrossRefGoogle ScholarPubMed
24.Urdahl, H, Manca, A, Sculpher, MJ. Assessing generalisability in model-based economic evaluation studies: A structured review in osteoporosis. Pharmacoeconomics. 2006;24:1181–1197.Google Scholar
25.Welte, R, Feenstra, T, Jager, H, Leidl, R. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics. 2004;22:857–876.CrossRefGoogle ScholarPubMed